At 80 weeks, all doses of retatrutide (4 mg, 9 mg, and 12 mg) met the primary and key secondary endpoints for obesity, delivering clinically meaningful weight loss
These statements have not been evaluated by the FDA and the compound is not intended to diagnose, treat, cure, or prevent any disease
If you change your behavior as well, you might have better luck at avoiding regain
While Phase 2 trials for Retatrutide showed promising results, the molecule is still being audited for long-term effects
They dont want the shame
Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, Attenuates Obesity-Induced Inflammation in the Nodose Ganglion, Hypothalamus, and Skeletal Muscle of Mice